Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.71	2.43	5.9	12.11	29.21
Cash & Short-Term Investments	10.71	2.43	5.9	12.11	29.21
Cash Growth	339.92%	-58.74%	-51.27%	-58.56%	162.75%
Other Receivables	-	-	-	1.61	-
Total Trade Receivables	-	-	-	1.61	-
Other Current Assets	0.28	0.55	0.62	0.8	0.95
Total Current Assets	10.99	2.99	6.52	14.52	30.16
Net Property, Plant & Equipment	0.04	-	-	-	-
Goodwill	-	-	-	-	8.87
Other Long-Term Assets	0.03	0.04	0.07	0.13	1.8
Total Assets	11.06	3.02	6.59	14.65	40.83
Accounts Payable	0.94	0.94	0.6	2.86	1.54
Accrued Expenses	0.86	0.35	0.41	1.41	0.57
Short-Term Debt	-	0.22	0.29	-	-
Unearned Revenue	3.23	-	-	-	-
Other Current Liabilities	0.14	-	-	-	-
Total Current Liabilities	5.17	1.51	1.3	4.27	2.11
Total Liabilities	5.17	1.51	1.3	4.27	2.11
Common Stock	0	0	0	0	0
Additional Paid-in Capital	100.33	83.44	81.64	74.19	70.92
Retained Earnings	-94.44	-81.92	-76.35	-63.81	-32.2
Shareholders' Equity	5.89	1.51	5.29	10.38	38.72
Total Liabilities & Equity	11.06	3.02	6.59	14.65	40.83
Total Debt	0	0.22	0.29	0	0
Net Cash (Debt)	10.71	2.21	5.61	12.11	29.21
Net Cash Growth	384.03%	-60.56%	-53.66%	-58.56%	174.53%
Net Cash Per Share	110.45	27.59	2474.67	8205.73	203397.57
Book Value	5.89	1.51	5.29	10.38	38.72
Book Value Per Share	60.73	18.85	2332.20	7038.72	269599.00
Tangible Book Value	5.89	1.51	5.29	10.38	29.86
Tangible Book Value Per Share	60.73	18.85	2332.20	7038.72	207872.00

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.